Why Prognos?
Prognos is a leading healthcare platform company transforming the ability to access, manage and analyze healthcare data. The company’s platform, prognosFACTORⓇ can query data points on 325M patients answering complex healthcare questions in seconds versus months. Customers include 25 of the top 30 pharmaceutical manufacturers and 3 of the top 5 payers. Our software enables purchasing healthcare data in the Prognos Marketplace specific to application business needs including cohort design, patient journey studies, health outcomes and more.
Market Opportunity
Prognos generates revenue through selling their platform capabilities to pharmaceutical manufacturers, commercial health plans and a variety of data partners. In addition, Prognos offers software applications for HEOR, risk management, and the commercial needs of the healthcare market. Based on current monetization strategies, the addressable healthcare analytics market for Prognos’ products is estimated to reach $40B by 2025.
Company Milestones
- Medivo acquires Physicians Wellness Network (PWN)
- Medivo becomes a Safeguard partner company
- Medivo launches free mobile and web-based app for hereditary angiodema
- Medivo acquires mobile health startup WellApps
- Medivo acquires diabetes management app OnTrack
- Medivo partners with NeoGenomics Laboratories to expand Medivo's Lab Value Exchange (LVX) database
- Medivo forms laboratory data liscensing agreement with Quest Diagnostics (NYSE:DGX)
- Medivo launches CareInsights Dx analytics solutions to help payers better manage risk and improve quality
- Medivo changes its name to Prognos
